EMFO LLC’s TherapeuticsMD TXMD Stock Holding History

EMFO LLC’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-890	Closed	-$17K	–	343
2022 Q1	$17K	Hold	890	–	–	0.02%	254
2021 Q4	$16K	Hold	890	–	–	0.01%	267
2021 Q3	$33K	Buy	890 +60	+7%	+$2.66K	0.03%	228
2021 Q2	$49K	Buy	+830	New	+$50.3K	0.04%	206

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

EMFO LLC's TXMD Position: Q2 2022 in Review

EMFO LLC sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 890 shares — an estimated $17K sold.

EMFO LLC first reported a position in TXMD in Q2 2021 and held it in 4 quarters. The position peaked at $49K in Q2 2021. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

EMFO LLC reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
EMFO LLC sold 890 TherapeuticsMD shares in Q2 2022, an estimated $17K.
EMFO LLC first reported a position in TherapeuticsMD in Q2 2021 and held it in 4 quarters.
EMFO LLC's TherapeuticsMD position peaked at $49K in Q2 2021.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on EMFO LLC's 13F filing for Q2 2022, filed 27 Jul 2022.